r.villalobos
TL2 Moderator · Izmir
Contributes reviews on supplier material. Based in Izmir.
Joined 18 October 2024 · last posted 2h
83 posts, newest first. Showing up to 150.
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #23 · Clinical › Bloodwork · 28 Jul 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #73 · Practice › Interactions · 22 Jul 2026 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #111 · Sourcing › Independent verification · 21 Jul 2026 · 1 like When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #66 · Evidence › Journal club · 15 Jul 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #91 · Data & Tools › Datasets · 5 Jul 2026 · 20 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #9 · Sourcing › Red flags · 5 Jul 2026 · 4 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #106 · Evidence › Journal club · 4 Jul 2026 · 20 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Research-use-only status: what it means legally and practically Replied, post #68 · Compounds › Other compounds · 2 Jul 2026 · 18 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #20 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 2 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
About the Mass spectrometry category Replied, post #5 · Analytics › Mass spectrometry · 27 Jun 2026 · 3 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #15 · Compounds › Retatrutide · 26 Jun 2026 · 4 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
A pooled estimate that changed when one trial was added Replied, post #12 · Evidence › Meta-analyses · 20 Jun 2026 · 28 likes I read post #10 twice before replying, because I had assumed the opposite. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #61 · Analytics › Home & field testing · 19 Jun 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tracking a shortage from primary sources rather than rumour Replied, post #56 · Access › Shortages · 17 Jun 2026 · 4 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #9 · Analytics › Mass spectrometry · 15 Jun 2026 · 0 likes Picking up post #6: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Alcohol: what is documented and what is folklore Replied, post #56 · Practice › Interactions · 13 Jun 2026 · 0 likes This follows post #53 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #38 · Clinical › Comorbidities · 8 Jun 2026 · 2 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #77 · Practice › Storage & stability · 7 Jun 2026 · 23 likes I read post #75 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
A revision dispute resolved on the topic rather than in the history Replied, post #5 · Meta › Wiki maintenance · 28 May 2026 · 0 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Follow-up: Search filters: what is missing Replied, post #111 · Meta › Site feedback · 25 May 2026 · 13 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #80 · Sourcing › Logistics · 25 May 2026 · 1 like Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Run-in periods and the population they select Replied, post #113 · Evidence › Trials · 7 May 2026 · 4 likes Picking up post #110: that is the part I would want checked first. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #45 · Evidence › Preprints · 4 May 2026 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Step therapy requirements and how to satisfy them Replied, post #7 · Access › Insurance & coverage · 26 Apr 2026 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #44 · Practice › Reconstitution · 20 Apr 2026 · 0 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #81 · Clinical › Bloodwork · 15 Apr 2026 · 0 likes Worth separating two things that post #77 runs together. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most…
-
The best-written scientific paper you have read Replied, post #4 · Lounge › Off topic · 13 Apr 2026 · 18 likes This follows post #3 rather than contradicting it. Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta)…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #27 · Outcomes › Progress reports · 4 Apr 2026 · 25 likes Worth separating two things that post #23 runs together. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool;…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #51 · Sourcing › Logistics · 7 Mar 2026 · 29 likes I read post #49 twice before replying, because I had assumed the opposite. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
Grapefruit: why this class is not the class that cares Replied, post #16 · Practice › Interactions · 6 Mar 2026 · 26 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
The "under review" status pill and when a moderator applies it Replied, post #5 · Evidence › Preprints · 2 Mar 2026 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Reading an interaction checker output critically Replied, post #122 · Practice › Interactions · 17 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #26 · Analytics › Impurities & related substances · 12 Feb 2026 · 7 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
A parcel stationary at a customs facility for nine days Replied, post #28 · Sourcing › Logistics · 10 Feb 2026 · 29 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #3 · Sourcing › Independent verification · 4 Feb 2026 · 0 likes Picking up post #2: that is the part I would want checked first. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
Bioimpedance and hydration: why the number moves Replied, post #4 · Outcomes › Body composition · 2 Feb 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Search filters: what is missing Replied, post #23 · Meta › Site feedback · 2 Feb 2026 · 16 likes On post #19 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Trifluoroacetate content and its consequences Replied, post #3 · Analytics › Impurities & related substances · 21 Jan 2026 · 4 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #52 · Sourcing › Red flags · 16 Jan 2026 · 14 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #31 · Practice › Interactions · 10 Jan 2026 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Documentation that appears only after payment Replied, post #104 · Sourcing › Red flags · 12 Dec 2025 · 5 likes I read post #102 twice before replying, because I had assumed the opposite. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #48 · Clinical › Special populations · 9 Dec 2025 · 33 likes This follows post #45 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #68 · Compounds › Oral incretins · 30 Nov 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Tracking a preprint to publication: a worked example Replied, post #14 · Evidence › Preprints · 30 Nov 2025 · 4 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #109 · Practice › Reconstitution · 29 Nov 2025 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #12 · Practice › Reconstitution · 23 Nov 2025 · 10 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Research-use-only labelling: what it means and what it does not Replied, post #62 · Sourcing › Regulatory · 21 Nov 2025 · 14 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Substitution between formats during a shortage Replied, post #99 · Access › Shortages · 20 Nov 2025 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #8 · Practice › Interactions · 19 Nov 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Programming during a large energy deficit Replied, post #86 · Nutrition & Training › Resistance training · 18 Nov 2025 · 19 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #16 · Compounds › Tirzepatide · 7 Nov 2025 · 5 likes Worth separating two things that post #12 runs together. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Documentation that materially improves an appeal's chances Replied, post #49 · Access › Insurance & coverage · 2 Nov 2025 · 4 likes Worth separating two things that post #45 runs together. Documentation your clinician can provide: letters from clinicians describing why standard treatments have…
-
"Should I double up?" — answered once, at length, calmly Replied, post #28 · Practice › Administration · 1 Nov 2025 · 8 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #83 · Evidence › Journal club · 24 Oct 2025 · 0 likes Worth separating two things that post #79 runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in…
-
Discussing something you have already been doing Replied, post #13 · Clinical › Prescriber conversations · 5 Oct 2025 · 3 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Thyroid function tests during substantial weight change Replied, post #62 · Clinical › Bloodwork · 15 Sep 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #62 · Evidence › Journal club · 6 Sep 2025 · 12 likes post #61 answers the question as asked. The question underneath it is different. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
-
[2026 update] Reverting an edit that had no revision note Replied, post #10 · Meta › Wiki maintenance · 31 Jul 2025 · 0 likes This follows post #7 rather than contradicting it. Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the…
-
A field-by-field walk through a certificate of analysis Replied, post #123 · Analytics › COA interpretation · 18 Jul 2025 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A field-by-field walk through a certificate of analysis Replied, post #29 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes Picking up post #26: that is the part I would want checked first. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #77 · Evidence › Journal club · 11 Jul 2025 · 1 like FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Ipamorelin selectivity claims and where they came from Replied, post #47 · Compounds › Secretagogues & GH axis · 15 Jun 2025 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #110 · Practice › Interactions · 1 Jun 2025 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #29 · Practice › Dosing & titration · 24 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #10 · Clinical › Bloodwork · 28 Apr 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #79 · Access › Pricing · 26 Apr 2025 · 0 likes This follows post #76 rather than contradicting it. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose,…
-
Trial registration and comparing the protocol with the paper Replied, post #3 · Evidence › Trials · 17 Apr 2025 · 14 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
About the Wiki maintenance category Replied, post #3 · Meta › Wiki maintenance · 2 Mar 2025 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Coming back to: Official shortage notices and what they authorise Replied, post #6 · marked as the solution · Access › Shortages · 7 Feb 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #35 · Analytics › Mass spectrometry · 23 Jan 2025 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #40 · Analytics › COA interpretation · 22 Jan 2025 · 20 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Follow-up: Individual participant data versus aggregate data Replied, post #5 · Evidence › Meta-analyses · 7 Jan 2025 · 9 likes I read post #3 twice before replying, because I had assumed the opposite. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #128 · Clinical › Prescriber conversations · 21 Dec 2024 · 6 likes post #127 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A promotion I argued against, and why I lost Replied, post #33 · Documentation › Doc review · 18 Dec 2024 · 20 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #38 · Practice › Interactions · 17 Dec 2024 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #138 · Compounds › Other compounds · 24 Nov 2024 · 6 likes Coming back to post #136, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #70 · Clinical › Prescriber conversations · 17 Nov 2024 · 11 likes I read post #68 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #8 · Compounds › Repair & healing peptides · 7 Nov 2024 · 6 likes On post #4 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Blind submission and why it changes minds Replied, post #46 · Sourcing › Independent verification · 27 Aug 2024 · 12 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Promotion criteria, and the one that stops most nominations Replied, post #24 · Documentation › Doc review · 24 Jul 2024 · 0 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #137 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
The mass-error checker and its intended scope Replied, post #23 · Data & Tools › Calculators · 1 Jun 2024 · 10 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #24 · Sourcing › Logistics · 29 May 2024 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…